Nationwide Survey on Treatment for Ischemic Stroke Patients with Cancer

January 1, 2026NosotchuOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to clarify the clinical practices regarding ischemic stroke in patients with cancer.
Conducted a nationwide survey from June to August 2023 across 960 primary stroke centers.
Collected data on cases of ischemic stroke with cancer, coexisting conditions, treatment methods, and outcomes from cases admitted within 7 days of onset in 2022.
Received responses from 173 facilities (18.0% response rate).
Out of 39,582 ischemic stroke cases, 1,941 (4.9%) had a cancer complication.
Atrial fibrillation was present in 30.8% of cases; 29.5% had intracranial or extracranial artery stenosis or occlusion.
Unfractionated heparin was used in 33.7% of acute treatments but decreased to 11.3% at discharge.

Nationwide survey investigates treatment patterns and outcomes for ischemic stroke patients with cancer, highlighting important trends in acute care.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Fujimoto et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share